Delving into the Latest Updates on Qinghai Yangzong Pharmaceutical Co., Ltd with Synapse

Overview

Tags

Endocrinology and Metabolic Disease

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Herbal medicine	1

主要目的：观察梓醇片在健康受试者单次和多次试验中的耐受性和安全性。次要目的：评价梓醇片在健康受试者中的单次给药、多次给药的药代动力学行为和药代动力学参数，初步探索梓醇片降糖作用以及药动药效学结合研究。

[Translation]

Primary objective: To observe the tolerability and safety of catalpol tablets in single and multiple trials in healthy subjects. Secondary objective: To evaluate the pharmacokinetic behavior and pharmacokinetic parameters of catalpol tablets in healthy subjects after single and multiple administrations, and to preliminarily explore the hypoglycemic effect of catalpol tablets and the pharmacokinetic-pharmacodynamic combination study.

Start Date26 Dec 2019

Sponsor / Collaborator

Qinghai Yangzong Pharmaceutical Co., Ltd

100 Clinical Results associated with Qinghai Yangzong Pharmaceutical Co., Ltd

Login to view more data

0 Patents (Medical) associated with Qinghai Yangzong Pharmaceutical Co., Ltd

Login to view more data

100 Deals associated with Qinghai Yangzong Pharmaceutical Co., Ltd

Login to view more data

100 Translational Medicine associated with Qinghai Yangzong Pharmaceutical Co., Ltd

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 15 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data